Susquehanna International Group
GMAB icon

Susquehanna International Group’s Genmab GMAB Stock Holding History

Susquehanna International Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87M Buy
106,800
+91,400
+594% +$2.74M ﹤0.01% 5360
2025
Q4 		$474K Buy
15,400
+3,100
+25% +$96.6K ﹤0.01% 8912
2025
Q3 		$377K Sell
12,300
-1,900
-13% -$46.3K ﹤0.01% 9603
2025
Q2 		$293K Sell
14,200
-24,100
-63% -$495K ﹤0.01% 10385
2025
Q1 		$750K Buy
38,300
+23,200
+154% +$487K ﹤0.01% 7982
2024
Q4 		$315K Buy
+15,100
New +$332K ﹤0.01% 9739
2024
Q2 		– Sell
-9,100
Closed -$272K – 12468
2024
Q1 		$272K Buy
9,100
+200
+2% +$5.88K ﹤0.01% 9921
2023
Q4 		$283K Sell
8,900
-17,200
-66% -$540K ﹤0.01% 9950
2023
Q3 		$921K Buy
26,100
+16,300
+166% +$621K ﹤0.01% 6811
2023
Q2 		$372K Sell
9,800
-106,500
-92% -$4.25M ﹤0.01% 8995
2023
Q1 		$4.39M Buy
116,300
+93,600
+412% +$3.6M ﹤0.01% 3646
2022
Q4 		$962K Sell
22,700
-8,200
-27% -$338K ﹤0.01% 6280
2022
Q3 		$993K Sell
30,900
-23,200
-43% -$815K ﹤0.01% 6647
2022
Q2 		$1.76M Buy
+54,100
New +$1.75M ﹤0.01% 5184
2021
Q4 		– Sell
-8,900
Closed -$389K – 13397
2021
Q3 		$389K Sell
8,900
-56,500
-86% -$2.54M ﹤0.01% 10002
2021
Q2 		$2.67M Buy
65,400
+4,700
+8% +$181K ﹤0.01% 5288
2021
Q1 		$1.99M Buy
+60,700
New +$2.28M ﹤0.01% 5930
2020
Q4 		– Sell
-10,000
Closed -$366K – 11266
2020
Q3 		$366K Buy
+10,000
New +$362K ﹤0.01% 8312

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Susquehanna International Group's GMAB Position: Q1 2026 in Review

Susquehanna International Group sold out of Genmab (GMAB) in Q1 2026, closing a stake of 612,323 shares — an estimated $18.4M sold.

Susquehanna International Group first reported a position in GMAB in Q4 2019 and held it in 22 quarters. The position peaked at $18.9M in Q4 2025. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Susquehanna International Group reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 612,323 Genmab shares in Q1 2026, an estimated $18.4M.
  • Susquehanna International Group first reported a position in Genmab in Q4 2019 and held it in 22 quarters.
  • Susquehanna International Group's Genmab position peaked at $18.9M in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.